Resignations Follow FDA approval of Alzheimer’s Drug; University Hospitals Focuses Healthcare Consumerism
- The approval by FDA of Biogen’s Alzheimer’s drug Aduhelm has led to the resignation of three committee members, citing disagreement with the department’s decision. The efficacy of the drug remains front and center of the public debate. UNIVERSITY HOSPITALS ADDRESSES HEALTHCARE CONSUMERISM Intuitive navigation and a system-wide...
